Boca Raton’s ModMed launches surgical software and names AI chief
Co-founder Dan Cane will lead AI strategy as Joe Harpaz becomes sole CEO; ModMed says its general-surgery platform is available now.
Key Takeaways
- •ModMed says its surgical platform combines records, documentation, practice management and revenue-cycle tools.
- •Dan Cane becomes the company’s first chief AI officer, while Joe Harpaz takes the sole CEO role.
- •AI-generated clinical summaries are planned; coding suggestions are intended for physician review.
Boca Raton healthcare software company ModMed says its new general-surgery platform is available now, following a leadership change that makes co-founder Dan Cane its first chief AI officer and Joe Harpaz its sole CEO.
The company’s Oct. 29 product announcement describes a system combining electronic health records, clinical documentation, practice management, patient engagement and revenue-cycle tools for general surgery and its subspecialties.
ModMed says its Scribe tool uses ambient listening to draft notes from patient-provider conversations and works with its electronic health record to suggest surgical diagnostic codes for physician review. The company also lists visual charting, reminders and follow-up communications among the platform’s capabilities.
The company describes AI-powered clinical summaries of patient histories as a planned feature. Its announcement says future functionality and timing are subject to change; it does not establish that those summaries are already available.
The product is aimed at an operating problem for surgical practices: coordinating documentation, scheduling and billing across office visits and procedures. ModMed describes the software’s intended functions, but its announcement does not establish independent evidence of better clinical outcomes or quantified savings for South Florida practices.
Who is leading the company
In an Oct. 28 leadership announcement, ModMed said Cane will guide AI strategy across products and internal operations, with executive responsibility for its revenue-cycle AI platform. Harpaz moves from a co-CEO role he had shared with Cane for the previous three years.
Celine Kaiser becomes chief operating officer, overseeing product management, customer success and the revenue-cycle management business. Co-founder Dr. Michael Sherling continues as chief medical and strategy officer, leading clinical and strategic initiatives. Both founders remain on the board, the company said.
ModMed said Scribe had supported nearly 3 million patient visits in the 11 months after its release. That company-reported usage figure describes activity, not a measured change in medical outcomes.
The company also named Luke Kervin and Travis Schneider to lead patient-engagement work. ModMed said its patient-engagement AI platform is planned for 2027. For practice operators considering the surgical offering, that future rollout is separate from the platform the company says is available now.
